Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients.

Hilde Skuterud Wik Susan R KahnHenry ErikssonDavid R Morrison Waleed Ghanima Sam Schulman Per Morten Sandset

Published in: Journal of thrombosis and haemostasis : JTH (2021)

In this long-term cross-sectional study, the prevalence of PTS, recurrent VTE, and HRQoL were similar in patients treated with dabigatran and warfarin.

Keyphrases

venous thromboembolism
atrial fibrillation
direct oral anticoagulants
cross sectional
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
risk factors
case report